BroadOak Capital Partners

BroadOak's Austin Duke participated in several panels and workshops to kick off the 2024 BioTools Innovator Summit.    BioTools Innovator was established to improve human health by accelerating the growth of a broad spectrum of life science tools and diagnostics. BioTools Innovator matches industry leaders with innovative early stage and emerging growth biotechnology-focused companies for mentorship and support.   BroadOak Capital Partners is proud to be a founding sponsor of BioTools Innovator, and we're excited to provide mentorship and support to the 2024 Cohort as they pioneer new biotech solutions.   #BroadOakCapitalPartners #InnovatorSummit2024 #lifesciencetools #biotools #techbio #BTI

Congratulations to PAK BioSolutions, a portfolio company of BroadOak’s BioTools Venture Fund, on their recent raise to expand commercial and product development. This financing validates all the great work that Joanna, Kevin, and their team have accomplished, as well as the exciting market opportunity for continuous manufacture of biologics. #biologics #investment #BioToolsVentureFund #BroadOak

We're proud to sponsor BioTools Innovator, which brings together entrepreneurs, industry leaders, and investors. This year's competition features 20 companies working to create revolutionary biotech products. Learn more about the 2024 BioTools Innovator Cohort https://lnkd.in/giF4HCi4 #BTI #BioToolsInnovator #Biotech #LifeScience #Biotools

Looking forward to representing BroadOak Capital Partners as a judge at the BioTools Innovator 2024 San Diego Pitch Event later this week. I was very impressed with the quality of startups, judges, and overall programming at the BioTools Innovator 2024 Boston Pitch Event a couple weeks ago. Having reviewed many of the companies in advance, this week's event should be equally as great.

Congratulations to the EmVenio Research team for their acquisition by PCM TRIALS - Quality Mobile Research. Together, they will continue to offer outstanding community-based clinical trials support. Learn more: https://lnkd.in/g4cA6PRa #clinicaltrials #news #acquisition #healthcare

We’re excited to host BroadOak Capital Partners’s Annual Investor Day in Bethesda, Maryland. Investor Day brings together industry experts, portfolio companies, and investors to network and discuss the latest life science tools and services trends. Thank you to seqWell, Active Motif, RoosterBio Inc., CDI Labs, and Particle Dynamics for presenting. #InvestorDay24 #LifeScience #Finance #Investment #BroadOakCapitalPartners

We are proud to attend Advanced Therapies Week. This year, BroadOak Vice President Daniel Friedman is a panelist for a discussion on investment opportunities in the life science tools industry and a judge for the annual Innovation Showcase.   We'll see you in Miami on January 16th for Advanced Therapies Week. Phacilitate #AdvancedTherapiesWeek #ATW24 #ATW #LifeScience #Miami

Congratulations to Interpace Biosciences on their continued profitable growth. The turnaround is impressive. https://lnkd.in/gEvPSdkK

We’re proud to sponsor BioTools Innovator and would like to congratulate this year’s winner, Limula, who offers a modular solution for on-demand and at-scale manufacturing of cell therapies in a single device. We also acknowledge and congratulate the other finalists: Andson Biotech, Aopia Biosciences, and BioRaptor. The grand prize winner received $250,000 and each other finalist received $10,000. The funds will be used to continue developing exciting new life science tools technologies. BroadOak Capital Partners Managing Director Austin Duke served as a judge for this year’s competition. Thank you to Austin and all the BioTools Innovator organizers for hosting a great event. #BioToolsInnovator #BTI #BTI23 #Biotech #LifeSciences